Dimensional Fund Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.04M Sell
2,928,736
-577,372
-16% -$993K ﹤0.01% 2519
2025
Q1
$11.7M Buy
3,506,108
+1,075,887
+44% +$3.58M ﹤0.01% 2182
2024
Q4
$18M Buy
2,430,221
+360,629
+17% +$2.67M ﹤0.01% 2034
2024
Q3
$19.4M Sell
2,069,592
-195,963
-9% -$1.84M ﹤0.01% 2015
2024
Q2
$18.2M Sell
2,265,555
-605,943
-21% -$4.86M ﹤0.01% 2005
2024
Q1
$42.6M Sell
2,871,498
-645,489
-18% -$9.57M 0.01% 1575
2023
Q4
$28.6M Sell
3,516,987
-461,398
-12% -$3.75M 0.01% 1799
2023
Q3
$18.1M Buy
3,978,385
+1,881,382
+90% +$8.56M 0.01% 1980
2023
Q2
$14.8M Buy
2,097,003
+587,770
+39% +$4.14M ﹤0.01% 2076
2023
Q1
$9.22M Sell
1,509,233
-143,128
-9% -$875K ﹤0.01% 2266
2022
Q4
$10.6K Sell
1,652,361
-10,152
-0.6% -$65 ﹤0.01% 2181
2022
Q3
$15.9M Buy
1,662,513
+415,153
+33% +$3.98M 0.01% 1946
2022
Q2
$13.8M Buy
1,247,360
+72,896
+6% +$805K ﹤0.01% 2062
2022
Q1
$19.6M Buy
1,174,464
+289,983
+33% +$4.83M 0.01% 1982
2021
Q4
$16.9M Buy
884,481
+553,559
+167% +$10.6M 0.01% 2074
2021
Q3
$8.16M Buy
330,922
+156,628
+90% +$3.86M ﹤0.01% 2417
2021
Q2
$4.54M Sell
174,294
-16,856
-9% -$439K ﹤0.01% 2641
2021
Q1
$6.04M Buy
191,150
+52,425
+38% +$1.66M ﹤0.01% 2507
2020
Q4
$6.44M Buy
138,725
+40,816
+42% +$1.89M ﹤0.01% 2438
2020
Q3
$3.22M Buy
97,909
+30,894
+46% +$1.02M ﹤0.01% 2598
2020
Q2
$1.84M Sell
67,015
-403,236
-86% -$11.1M ﹤0.01% 2785
2020
Q1
$14.1M Sell
470,251
-304,740
-39% -$9.12M 0.01% 1942
2019
Q4
$21.5M Sell
774,991
-39,528
-5% -$1.09M 0.01% 2010
2019
Q3
$14.8M Sell
814,519
-1,420
-0.2% -$25.8K 0.01% 2169
2019
Q2
$20M Buy
815,939
+458,811
+128% +$11.3M 0.01% 2051
2019
Q1
$3.4M Hold
357,128
﹤0.01% 2765
2018
Q4
$3.16M Buy
357,128
+326,531
+1,067% +$2.89M ﹤0.01% 2729
2018
Q3
$344K Buy
+30,597
New +$344K ﹤0.01% 3234